Clinical trial Recruiting at 1 site Observational Ages 18 to 60

Gut–brain gut study in IBS with anxiety and depression

Official title: Investigating the Brain-Gut Axis Regulatory Mechanism of Anxiety and Depression in Irritable Bowel Syndrome

Run by Tang-Du Hospital · NCT07646834 · Data updated 2026-11-12

This study will compare people with IBS and mood symptoms to healthy volunteers to see if gut bacteria relate to brain function using questionnaires, stool and blood samples, and a brain MRI.

Quick facts

Study typeObservational
Ages18 Years to 60 Years
SexAll
Enrollment200 (estimated)
SponsorTang-Du Hospital
Academic / other
Locations1 site (Xi'an, Shaanxi)
StatusRecruiting
StartedDecember 21, 2025
Main results expectedDecember 21, 2026
Study endsDecember 30, 2027
Registry record updatedJune 15, 2026
Trial IDNCT07646834 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18-60 who have IBS with anxiety or depression and are right-handed, not using anti-anxiety or antidepressant medications, and able to undergo a 7 Tesla MRI.

Probably not a fit

IBS patients not experiencing anxiety or depression, non-right-handed individuals, or those unable to tolerate MRI could see no direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study enrolls 200 adults aged 18-60, with 100 IBS patients who have anxiety or depression and 100 healthy controls, all right-handed. Participants provide stool and blood samples, complete questionnaires on bowel symptoms and mental health, and undergo a 7 Tesla MRI brain scan lasting about 45-50 minutes. The goal is to explore connections between gut microbiota and brain activity and to identify potential markers for diagnosis or future therapies. No new treatments are administered during the study. Inclusion requires Rome IV-confirmed IBS with specific symptom criteria and no prior use of anti-anxiety or antidepressant medications.

Why it matters

Potential benefit: Discover potential biomarkers that could aid in diagnosing IBS with mood symptoms and guide future treatment approaches.

How similar studies have gone: Prior brain–gut studies have shown links between gut microbiota and brain function in GI and mood disorders, supporting feasibility of this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Right-handed, aged 18-60 years, with more than 6 years of education;
2. Meeting the Rome IV diagnostic criteria for IBS: Symptoms have been present for at least 6 months, and for the last 3 months, the following criteria are met: recurrent abdominal pain or discomfort, with symptoms occurring on at least 3 days per month in the last 3 months, associated with two or more of the following: 1) Improvement with defecation; 2) Onset associated with a change in frequency of stool; 3) Onset associated with a change in form (appearance) of stool;
3. The following symptoms support the diagnosis of IBS: 1) Abnormal stool frequency: \<3 bowel movements per week or \>3 bowel movements per day; 2) Abnormal stool form: lumpy/hard stool or mushy/watery stool; 3) Straining during defecation; 4) Urgency or a feeling of incomplete evacuation; 5) Passage of mucus; 6) Bloating.

Exclusion Criteria:

1. History of anti-anxiety/depressant medication use (e.g., SSRI/SNRI, Chinese patent medicines) within the past 1 month;
2. History of antibiotic or probiotic use within the past 1 month;
3. Other gastrointestinal diseases such as IBD, intestinal obstruction, or history of gastrointestinal surgery;
4. Current or past history of psychiatric or neurological disorders, such as psychosis, brain tumors, or impaired consciousness;
5. Concurrent severe hepatic or renal insufficiency, cardiovascular or cerebrovascular diseases, or malignant tumors; 7.0T MRI Contraindications: Presence of ferromagnetic implants (e.g., cardiac pacemakers, defibrillators, neurostimulators, aneurysm clips, cochlear implants, or any metallic foreign bodies); Non-ferromagnetic implants (e.g., titanium alloy, orthopedic implants), various types of intrauterine devices, various types of non-removable dentures (including dental implants); Presence of metallic foreign bodies (e.g., metal fragments, shrapnel, or filings in the eyes or body), such as in individuals engaged in welding work or with a history of metal item trauma; Tattoos or permanent makeup (e.g., eyebrows, lips) applied within the past month; Claustrophobia; Fever.

HC Group Inclusion Criteria (all must be met):

1. Right-handed, aged 18-60 years, with more than 6 years of education;
2. All physiological indicators are within normal ranges, with no signs of disease;
3. No family history of psychiatric or neurological disorders.

Where it's running

  • Tangdu Hospital, Air Force Medical University
    Xi'an, Shaanxi, China
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.